Heart Core B.V. deploys HeartLab's CardioNow

TriMed Staff | | Health Imaging | Screening
Heartlab Inc. has completed its first European core lab installation of HeartLab's CardioNow DICOM telecardiology and image management system for cardiovascular device and drug studies at Heart Core B.V. in the Netherlands.

Heart Core B.V. will now be able to offer its clients HeartLab's web-based CardioNow system to improve the receiving, tracking, archiving and analysis of cardiac images from hospital sites around the world. CardioNow enables hospitals investigator sites around the world to share DICOM studies required by certain cardiovascular drug and device clinical trials, HeartLab said.

The installation is the fifth cardiovascular core lab to utilize HeartLab's web-based system for trial image management.

TriMed Staff

Related Content

Routine abdominal CTs offer insight into cardiovascular risk
Screening efforts have helped avert millions of cancer-related deaths in recent decades
What breast density status can tell us about cardiovascular risk
FDA clears AI tool that flags signs of heart disease in chest CT scans
Patients without PCPs struggle to access lung cancer screening, despite eligibility
Breast cancer rates among women in their 30s are on the rise

Around the web

Radiology Business
The biggest challenges facing radiology business managers in 2025

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.